Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pracinostat with Azacitidine in Elderly Newly Diagnosed AML
NCT01912274Phase 2Completed
- Sponsor
- Helsinn
- Start
- Dec 2013
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pracinostat in acute myeloid leukemia (AML), sponsored by Helsinn. Started Dec 2013; status: completed.
02
Drugs
pracinostat
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01912274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01912274.